Leading Kidney Care Platform slide image

Leading Kidney Care Platform

Free cash flow from continuing operations (in millions) Net cash provided by continuing operating activities Less: Distributions to noncontrolling interests Plus: Contributions to noncontrolling interests Cash provided by continuing operating activities attributable to DaVita Inc. Less: Expenditures for routine maintenance and information technology Less: Expenditures for development Plus: Proceeds from sale of self-developed properties Free cash flow from continuing operations 64 © 2021 DaVita Inc. All rights reserved. Nine months ended September 30, 2021 2019 2020 $ (233) 1,973 $ 1,979 (253) $ 1,401 (177) 57 43 28 1,797 1,769 1,252 (355) (399) (289) (373) (275) (163) 58 93 43 $ 1,127 $ 1,188 $ 843 *
View entire presentation